Specialists approach the clinical perspective of this therapeutic alternative at SOMALAB’s Inaugural Event, the first Medical Cannabis Research Symposium that took place in UNAM.
At the UNAM, academics, representatives of the pharmaceutical industry and specialists in cannabis medicine participate in the Pharmaceutical Medical Symposium on Cannabinoids, which addresses the clinical perspective of this therapeutic alternative.
They emphasize the benefits of this type of medicines in the treatment of pain, to combat chronic inflammatory diseases, and in psychiatry.
However, one issue that coincides is the importance of conducting research for the development of new drugs.
Read the full story from ONCE NOTICIAS at: